Neopharma

📍 Abu Dhabi, United Arab Emirates🗓 Founded 2003👥 407 employees💰 Last funded Mar 2000
Pharmaceutical Manufacturing🌐 neopharma.com
Website LinkedIn
Neopharma is one of the largest pharmaceutical companies in MENA region with 100% subsidiaries in USA, Japan, Brazil, UK and India. A vertically integrated business, comprising of Key intermediaries, API, R&D and Formulation facilities in regulated and emerging markets. Our global presence is supported by 10 manufacturing facilities spread across 3 continents delivering a wide range of branded & generic formulations, and active pharmaceutical ingredients (APIs). The therapeutic segments covered are acute and chronic therapies and having strong foot hold in anti-infective segment. Neopharma is primarily focusing on novel therapeutics, increasing portfolio depth and debilitating diseases at affordable prices.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2003
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in Neopharma?
Neopharma has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Neopharma last raise funding?
The most recent investment in Neopharma recorded on gritt.io was in March 2000.
When was Neopharma founded?
Neopharma was founded in 2003.
What industry is Neopharma in?
Neopharma operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Neopharma based?
Neopharma is headquartered in Abu Dhabi, United Arab Emirates.